Executive Summary
The Insider Trading Pulse for 2026-10-28 covers 50 SEC Form 4 filings, and the dominant story is heavy insider selling concentrated in DRDGOLD LTD, where eight officers exercised conditional share awards and sold shares at a uniform $2.44, a pattern that suggests a coordinated liquidity event rather than discretionary timing.
Counterbalancing this, several accumulation signals emerged: Accenture's Chair and CEO bought roughly $2.49M of stock at $246.17, XBiotech's director bought about $711K, and Huntington Bancshares directors bought preferred shares alongside a cluster of routine director equity awards. Bank and financial names show mixed activity, with Fifth Third's CIO and State Street's Chief Risk Officer selling under 10b5-1 plans, while Huntington insiders were largely recipients of awards rather than sellers. Large-value sales in the scope included Travelers' EVP selling about $4.33M after an option exercise and Roper's CLO selling about $1.57M, both material to materiality scoring. Several filings carry no enriched period-over-period, guidance, or capital allocation data, so the digest cannot assess quantitative trend shifts and relies on transaction-level signals. Overall the day skews toward insider distribution in value terms, but the Accenture and XBiotech purchases are the clearest conviction signals.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4
Tracking the trend? Catch up on the prior Insider Trading Pulse digest from October 20, 2026.
Investment Signals (10)
- Accenture plc ↓ (BULLISH)▲
Chair and CEO Sweet Julie Spellman bought 10,100 shares at $246.17 (~$2.49M) after a 2,100-share purchase at $245.11, holding 48,910 shares afterward; materiality 8/10
- XBiotech Inc. ↓ (BULLISH)▲
Director SIMARD JOHN bought 368,524 shares at $1.93 (~$711K), lifting holdings to 4,191,690 shares, a clear open-market conviction buy
- Accenture plc ↓ (BULLISH)▲
Director Price Paula A added 800 shares at $249.81 (~$200K), reinforcing insider buying at the company alongside the CEO purchase
- Flagstar Bank, N.A. (BULLISH)▲
Director Frank Alan L bought 10,000 shares at $10.14 (~$101K), bringing holdings to 76,463 shares
- Huntington Bancshares ↓ (BULLISH)▲
Director ROLLINS JAMES D III bought 10,000 shares of 5.70% Series I preferred at $19.43 (~$194K) and 4,000 shares of 4.50% Series H preferred at $14.86 (~$59.4K), a sizable preferred-stock buying signal
- LCNB Corp ↓ (BULLISH)▲
Director Krehbiel Anne E bought 1,000 shares at $19.79 (~$19.8K), holding 13,122 shares
- Travelers Companies ↓ (BEARISH)▲
EVP Lefebvre Mojgan M sold 11,000 shares at $393.84 (~$4.33M) after exercising options at $139.83, and retains no remaining shares per the filing
- Roper Technologies ↓ (BEARISH)▲
EVP and CLO Stipancich John K sold 3,500 shares at $449.04 (~$1.57M) after exercising options at $275.69, a sale of roughly $1.57M with 35,434 shares retained
- Veracyte, Inc. ↓ (BEARISH)▲
Director EASTHAM KARIN sold 14,850 shares at $50.00 (~$743K) under a 10b5-1 plan following option exercises, leaving 10,247 shares
- DRDGOLD LTD ↓ (BEARISH)▲
Eight officers, including the CEO (117,980 shares, ~$288K) and COO (94,575 shares, ~$231K), exercised conditional share awards and sold at $2.44, a coordinated pattern totaling several hundred thousand dollars in sales
Risk Flags (8)
- DRDGOLD LTD/Coordinated Insider Selling↓ [HIGH RISK]▼
Eight officers across production, technical, financial and executive roles sold stock at an identical $2.44 price immediately after converting conditional share awards, with the CEO selling about $288K and the COO about $231K; the uniform pricing suggests a structured liquidation rather than individual discretion
- Amber International Holding Ltd/Governance↓ [HIGH RISK]▼
CEO Wu Yuao disposed of 309,834,748 Class A shares against acquisitions of 69,552,266 and 19,458,931 shares, a net reduction on a scale far above typical filings, with 2,287,892 shares retained; the 15 transactions warrant review of the reporting context
- Travelers Companies/Large Officer Exit↓ [HIGH RISK]▼
EVP Lefebvre sold its entire disclosed position of 11,000 shares (~$4.33M) after option exercises, showing a full divestiture by a senior technology and operations officer
- Fifth Third Bancorp/Ongoing Distribution↓ [MEDIUM RISK]▼
EVP & CIO Schramm Jude sold shares across 26 transactions in the filing, including several small blocks near $53.05, indicating sustained selling rather than a single event
- Veracyte, Inc./Repeated Director Sales↓ [MEDIUM RISK]▼
Director Holstein Jens sold 7,500 shares at $50.00 (~$375K) and an additional 7,500 shares at $47.00 (~$353K) after 10b5-1 option exercises, a recurring pattern of director monetization at the company
- Paylocity Holding/Director Distribution↓ [MEDIUM RISK]▼
Director Sarowitz Steven I sold across five transactions, including 4,500 shares at $170.44 (~$767K), while still holding about 4.35 million shares, indicating ongoing planned diversification
- Dime Community Bancshares/Director Exit↓ [MEDIUM RISK]▼
Director Perry Joseph sold 3,000 Series A preferred shares at $16.88 (~$50.6K) and gifted additional shares, while Chief Technology Officer Fegan Michael sold 2,355 shares at $41.81 (~$98.5K)
- Verizon Communications/Planned Sale↓ [LOW RISK]▼
EVP Malady Kyle sold 1,100 shares at $43.00 (~$47.3K) under a Rule 10b5-1 plan, a modest sale but an executive-level reduction at a large-cap name
Opportunities (6)
- Accenture plc/Insider Conviction↓ (OPPORTUNITY)◆
CEO purchase of $2.49M and director purchase of $200K at prices of $245–$250 signal management confidence at current levels, a strong alignment signal for a large-cap name with materiality 8/10
- XBiotech Inc./Director Accumulation↓ (OPPORTUNITY)◆
Director Simard's $711K purchase at $1.93 raised holdings to 4.19 million shares, and the purchase size relative to a sub-$2 price points to a potentially undervalued entry for investors
- Huntington Bancshares/Preferred Stock Buying↓ (OPPORTUNITY)◆
Director Rollins bought about $254K of preferred shares across two series (Series I at $19.43 and Series H at $14.86), offering income-oriented exposure alongside a broad cluster of director equity awards signaling board alignment
- Flagstar Bank/Director Buying↓ (OPPORTUNITY)◆
Director Frank's $101K open-market purchase at $10.14 indicates insider valuation support at a bank name with a modest price level
- LCNB Corp/Community Bank Insider Buy↓ (OPPORTUNITY)◆
Director Krehbiel's 1,000-share purchase at $19.79 adds a small but clean open-market signal at a regional bank
- Stock Yards Bancorp/Director Equity Award↓ (OPPORTUNITY)◆
Director Hardy received 96 shares at $79.19 (~$7.6K), a small award that nonetheless reflects continued board equity participation at a regional bank
Sector Themes (5)
- Mining Insider Liquidity Event◆
All DRDGOLD filings in the set show identical mechanics, with conditional share awards exercised and sold at $2.44, and the combined sales across Chief Executive, COO, CFO and multiple managers suggest a company-wide vesting or liquidity event rather than individual timing decisions. Eight of the 50 filings (16%) come from this single issuer.
- Regional Banks Show Mixed Insider Flows◆
Among bank filings (Dime, FS Bancorp, Washington Trust, Fifth Third, State Street, Flagstar, Huntington, LCNB, Stock Yards, Beacon), buying appears in Flagstar, LCNB, Beacon and Huntington preferred purchases, while selling appears at Dime, Washington Trust, Fifth Third and State Street. Net flow is roughly balanced across the sector with no dominant direction.
- Director Equity Awards Dominate Huntington◆
Huntington Bancshares contributed six filings, most of them director awards of 949 to 3,252 shares of common stock, pointing to routine board compensation rather than discretionary trading. The single preferred purchase by Rollins is the notable exception within that cluster.
- Biotech and Life Sciences Mixed Signals◆
Intellia, Agios, Vir, Castle Biosciences, Beta Bionics, Fulgent Genetics and XBiotech show a blend of option-related sales (Agios, Castle), equity awards (Intellia, Vir, Lightwave Logic) and one large director purchase (XBiotech), with no clear sector-wide directional trend.
- Large-Cap Executive Sales Under 10b5-1 Plans◆
Several sales in the set were executed under Rule 10b5-1 plans, including Verizon, Sturm Ruger, Castle Biosciences, State Street, Veracyte, Agios, Paylocity, Fiverr and Beta Bionics, indicating that much of the selling reflects pre-scheduled diversification rather than near-term views, which lowers the signal weight of these sales.
Watch List (6)
-
Eight officers sold stock at $2.44 after conditional award conversions; monitor for further vesting-related sales and whether the uniform pricing persists in subsequent Form 4 filings [2026-10-28 filing date]
-
CEO and director open-market purchases at $245–$250 are a conviction signal to track for follow-on buying or price reaction in the next earnings window
-
The reported 309.8 million-share disposal by the CEO is an outsized transaction; watch for amended filings or clarification on the 15-transaction reporting context
-
With the EVP's full position reportedly sold after option exercises, monitor whether other Travelers officers follow with similar post-exercise sales
-
Repeated director sales under 10b5-1 plans (Holstein and Eastham) indicate a pattern of planned monetization; track whether additional directors adopt similar plans
-
The preferred stock purchase by Director Rollins is a distinct signal amid routine award activity; watch for other directors buying preferred series
Filing Analyses
(50)
28-10-2026
Chief Executive Officer Wu Yuao disposed of 309,834,748 Class A ordinary shares, par value $0.001 per share. 15 transactions reported in total. Wu Yuao holds 2,287,892 shares after the transaction.
- · Chief Executive Officer Wu Yuao disposed of 309,834,748 Class A ordinary shares, par value $0.001 per share
- · Chief Executive Officer Wu Yuao acquired 69,552,266 Class A ordinary shares, par value $0.001 per share
- · Chief Executive Officer Wu Yuao acquired 19,458,931 Class A ordinary shares, par value $0.001 per share
- · Chief Executive Officer Wu Yuao acquired 6,698,479 Class A ordinary shares, par value $0.001 per share
- · Chief Executive Officer Wu Yuao acquired 4,620,646 Class A ordinary shares, par value $0.001 per share
- · Chief Executive Officer Wu Yuao disposed of 11,729,691 Class A ordinary shares, par value $0.001 per share
- · Chief Executive Officer Wu Yuao disposed of 6,225,342 Class A ordinary shares, par value $0.001 per share
- · Chief Executive Officer Wu Yuao disposed of 18,147,222 Class A ordinary shares, par value $0.001 per share
28-10-2026
Chair and CEO Sweet Julie Spellman bought 10,100 Class A ordinary shares at $246.17 (~$2.49M). Sweet Julie Spellman holds 48,910 shares after the transaction.
- · Chair and CEO Sweet Julie Spellman bought 2,100 Class A ordinary shares at $245.11 (~$515K)
- · Chair and CEO Sweet Julie Spellman bought 10,100 Class A ordinary shares at $246.17 (~$2.49M)
28-10-2026
Director Price Paula A bought 800 Class A ordinary shares at $249.81 (~$200K). Price Paula A holds 9,361 shares after the transaction.
- · Director Price Paula A bought 800 Class A ordinary shares at $249.81 (~$200K)
28-10-2026
Director Fitzgerald Margaret Boles bought 329 Common Stock at $30.77 (~$10.1K). Fitzgerald Margaret Boles holds 18,909 shares after the transaction.
- · Director Fitzgerald Margaret Boles bought 329 Common Stock at $30.77 (~$10.1K)
28-10-2026
Director Silverman Alan gifted 300 common stock. Silverman Alan holds 24,180.7899 shares after the transaction.
- · Director Silverman Alan gifted 300 common stock
28-10-2026
Chief Operating Officer Malka Gabriel was awarded 11,000 Ordinary shares. Malka Gabriel holds 58,922 shares after the transaction.
- · Chief Operating Officer Malka Gabriel was awarded 11,000 Ordinary shares
28-10-2026
10% owner ENDEAVOR FOUNDATION, INC. gifted 18,000 Common Stock. ENDEAVOR FOUNDATION, INC. holds 9,432,785 shares after the transaction.
- · 10% owner ENDEAVOR FOUNDATION, INC. gifted 18,000 Common Stock
28-10-2026
Director ZHANG KAIFU had withheld for taxes 4,248 American Depositary Shares at $10.24 (~$43.5K). 4 transactions reported in total. ZHANG KAIFU holds 64,892 shares after the transaction.
- · Director ZHANG KAIFU exercised/converted 15,300 American Depositary Shares
- · Director ZHANG KAIFU had withheld for taxes 4,248 American Depositary Shares at $10.24 (~$43.5K)
- · Director ZHANG KAIFU exercised/converted 15,300 Restricted Stock Units (RSU)
- · Director ZHANG KAIFU was awarded 35,307 Stock Option (Right to Buy)
28-10-2026
Director Krehbiel Anne E bought 1,000 LCNB Corp Common Stock at $19.79 (~$19.8K). Krehbiel Anne E holds 13,122 shares after the transaction.
- · Director Krehbiel Anne E bought 1,000 LCNB Corp Common Stock at $19.79 (~$19.8K)
28-10-2026
Chief Home Lending, EVP COSTA DONN C had withheld for taxes 36,800 Common Stock at $43.77 (~$1.61M). COSTA DONN C holds 76,172 shares after the transaction.
- · Chief Home Lending, EVP COSTA DONN C exercised/converted 36,800 Common Stock at $29.30 (~$1.08M)
- · Chief Home Lending, EVP COSTA DONN C had withheld for taxes 36,800 Common Stock at $43.77 (~$1.61M)
- · Chief Home Lending, EVP COSTA DONN C exercised/converted 36,800 Stock Option (Right to Buy)
28-10-2026
Chief Financial Officer Hooijer Henriette sold 22,687 Ordinary Shares at $2.44 (~$55.4K). 4 transactions reported in total. Hooijer Henriette holds 199,827 shares after the transaction.
- · Chief Financial Officer Hooijer Henriette exercised/converted 50,415 Ordinary Shares
- · Chief Financial Officer Hooijer Henriette sold 22,687 Ordinary Shares at $2.44 (~$55.4K)
- · Chief Financial Officer Hooijer Henriette exercised/converted 50,415 Conditional Share Awards
- · Chief Financial Officer Hooijer Henriette disposed of 33,610 Conditional Share Awards
28-10-2026
Chief Executive Officer Pretorius Daniel sold 117,980 Ordinary Shares at $2.44 (~$288K). 4 transactions reported in total. Pretorius Daniel holds 1,144,012 shares after the transaction.
- · Chief Executive Officer Pretorius Daniel exercised/converted 262,176 Ordinary Shares
- · Chief Executive Officer Pretorius Daniel sold 117,980 Ordinary Shares at $2.44 (~$288K)
- · Chief Executive Officer Pretorius Daniel exercised/converted 262,176 Conditional Share Awards
- · Chief Executive Officer Pretorius Daniel disposed of 174,783 Conditional Share Awards
28-10-2026
Head of Prod., Dir. of Ergo Gouws Henry sold 89,160 Ordinary Shares at $2.44 (~$218K). 4 transactions reported in total. Gouws Henry holds 3,050 shares after the transaction.
- · Head of Prod., Dir. of Ergo Gouws Henry exercised/converted 89,160 Ordinary Shares
- · Head of Prod., Dir. of Ergo Gouws Henry sold 89,160 Ordinary Shares at $2.44 (~$218K)
- · Head of Prod., Dir. of Ergo Gouws Henry exercised/converted 89,160 Conditional Share Awards
- · Head of Prod., Dir. of Ergo Gouws Henry disposed of 59,440 Conditional Share Awards
28-10-2026
Director SIMARD JOHN bought 368,524 Common Stock at $1.93 (~$711K). SIMARD JOHN holds 4,191,690 shares after the transaction.
- · Director SIMARD JOHN bought 368,524 Common Stock at $1.93 (~$711K)
28-10-2026
Head of Technical Services Kruger Kevin sold 73,830 Ordinary Shares at $2.44 (~$180K). 4 transactions reported in total. Kruger Kevin holds 9,240 shares after the transaction.
- · Head of Technical Services Kruger Kevin exercised/converted 73,830 Ordinary Shares
- · Head of Technical Services Kruger Kevin sold 73,830 Ordinary Shares at $2.44 (~$180K)
- · Head of Technical Services Kruger Kevin exercised/converted 73,830 Conditional Share Awards
- · Head of Technical Services Kruger Kevin disposed of 49,219 Conditional Share Awards
28-10-2026
Financial Manager Ergo Ops. Bornman Ryno sold 8,388 Ordinary Shares at $2.44 (~$20.5K). 4 transactions reported in total. Bornman Ryno holds 16,959 shares after the transaction.
- · Financial Manager Ergo Ops. Bornman Ryno exercised/converted 18,639 Ordinary Shares
- · Financial Manager Ergo Ops. Bornman Ryno sold 8,388 Ordinary Shares at $2.44 (~$20.5K)
- · Financial Manager Ergo Ops. Bornman Ryno exercised/converted 18,639 Conditional Share Awards
- · Financial Manager Ergo Ops. Bornman Ryno disposed of 12,425 Conditional Share Awards
28-10-2026
EVP and Group CEO-VZ Business Malady Kyle sold 1,100 Common Stock at $43.00 (~$47.3K). Malady Kyle holds 98,866 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · EVP and Group CEO-VZ Business Malady Kyle sold 1,100 Common Stock at $43.00 (~$47.3K)
28-10-2026
General Manager FWGR Ops. Moloto Kgabo sold 21,999 Ordinary Shares at $2.44 (~$53.7K). 4 transactions reported in total. Moloto Kgabo holds 21,999 shares after the transaction.
- · General Manager FWGR Ops. Moloto Kgabo exercised/converted 21,999 Ordinary Shares
- · General Manager FWGR Ops. Moloto Kgabo sold 21,999 Ordinary Shares at $2.44 (~$53.7K)
- · General Manager FWGR Ops. Moloto Kgabo exercised/converted 21,999 Conditional Share Awards
- · General Manager FWGR Ops. Moloto Kgabo disposed of 14,665 Conditional Share Awards
28-10-2026
General Manager Ergo Ops. Lindecke Dean sold 48,948 Ordinary Shares at $2.44 (~$119K). 4 transactions reported in total. Lindecke Dean holds 48,948 shares after the transaction.
- · General Manager Ergo Ops. Lindecke Dean exercised/converted 48,948 Ordinary Shares
- · General Manager Ergo Ops. Lindecke Dean sold 48,948 Ordinary Shares at $2.44 (~$119K)
- · General Manager Ergo Ops. Lindecke Dean exercised/converted 48,948 Conditional Share Awards
- · General Manager Ergo Ops. Lindecke Dean disposed of 32,631 Conditional Share Awards
28-10-2026
Chief Operating Officer Schoeman Jacobus sold 94,575 Ordinary Shares at $2.44 (~$231K). 4 transactions reported in total. Schoeman Jacobus holds 70,000 shares after the transaction.
- · Chief Operating Officer Schoeman Jacobus exercised/converted 139,575 Ordinary Shares
- · Chief Operating Officer Schoeman Jacobus sold 94,575 Ordinary Shares at $2.44 (~$231K)
- · Chief Operating Officer Schoeman Jacobus exercised/converted 139,575 Conditional Share Awards
- · Chief Operating Officer Schoeman Jacobus disposed of 93,049 Conditional Share Awards
28-10-2026
Financial Manager FWGR Ops. Laas Lihan sold 14,787 Ordinary Shares at $2.44 (~$36.1K). 4 transactions reported in total. Laas Lihan holds 14,787 shares after the transaction.
- · Financial Manager FWGR Ops. Laas Lihan exercised/converted 14,787 Ordinary Shares
- · Financial Manager FWGR Ops. Laas Lihan sold 14,787 Ordinary Shares at $2.44 (~$36.1K)
- · Financial Manager FWGR Ops. Laas Lihan exercised/converted 14,787 Conditional Share Awards
- · Financial Manager FWGR Ops. Laas Lihan disposed of 9,857 Conditional Share Awards
28-10-2026
Director Santos Edwin J sold 1,200 Common Stock at $39.25 (~$47.1K). Santos Edwin J holds 9,110 shares after the transaction.
- · Director Santos Edwin J sold 1,200 Common Stock at $39.25 (~$47.1K)
28-10-2026
Director Topalian Suzanne Louise was awarded 8,000 Common Stock. 4 transactions reported in total. Topalian Suzanne Louise holds 12,731 shares after the transaction.
- · Director Topalian Suzanne Louise was awarded 8,000 Common Stock
- · Director Topalian Suzanne Louise was awarded 4,731 Common Stock
- · Director Topalian Suzanne Louise was awarded 16,000 Stock Option (Right to Buy)
- · Director Topalian Suzanne Louise was awarded 9,462 Stock Option (Right to Buy)
28-10-2026
Director Perry Joseph sold 3,000 Preferred Stock, Series A at $16.88 (~$50.6K). Perry Joseph holds 54,806 shares after the transaction.
- · Director Perry Joseph sold 3,000 Preferred Stock, Series A at $16.88 (~$50.6K)
- · Director Perry Joseph gifted 194 The Joseph John Perry Rev. Trust
28-10-2026
Director Frank Alan L bought 10,000 Common Stock at $10.14 (~$101K). Frank Alan L holds 76,463 shares after the transaction.
- · Director Frank Alan L bought 10,000 Common Stock at $10.14 (~$101K)
28-10-2026
VP of New Product Development Wilson Michael W sold 628 Common Stock at $45.47 (~$28.6K). Trades executed under a Rule 10b5-1 plan.
- · VP of New Product Development Wilson Michael W sold 628 Common Stock at $45.47 (~$28.6K)
28-10-2026
Chief Operating Officer Beade Guillermo Hugo was awarded 129,390 Restricted Stock Units.
- · Chief Operating Officer Beade Guillermo Hugo was awarded 129,390 Restricted Stock Units
28-10-2026
Chief Commercial Officer Juvenal Tobin W sold 3,288 Common Stock at $33.08 (~$109K). Juvenal Tobin W holds 45,431 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Commercial Officer Juvenal Tobin W sold 3,288 Common Stock at $33.08 (~$109K)
28-10-2026
EVP & CIO Schramm Jude sold 3,032 Common Stock at $53.18 (~$161K). 26 transactions reported in total. Schramm Jude holds 121,460 shares after the transaction.
- · EVP & CIO Schramm Jude sold 800 Common Stock at $53.04 (~$42.4K)
- · EVP & CIO Schramm Jude sold 400 Common Stock at $53.05 (~$21.2K)
- · EVP & CIO Schramm Jude sold 400 Common Stock at $53.06 (~$21.2K)
- · EVP & CIO Schramm Jude sold 400 Common Stock at $53.07 (~$21.2K)
- · EVP & CIO Schramm Jude sold 300 Common Stock at $53.08 (~$15.9K)
- · EVP & CIO Schramm Jude sold 1,691 Common Stock at $53.09 (~$89.8K)
- · EVP & CIO Schramm Jude sold 900 Common Stock at $53.10 (~$47.8K)
- · EVP & CIO Schramm Jude sold 400 Common Stock at $53.12 (~$21.2K)
28-10-2026
Director Holstein Jens sold 7,500 Common Stock at $50.00 (~$375K). 6 transactions reported in total. Holstein Jens holds 27,471 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Holstein Jens exercised/converted 7,500 Common Stock at $35.30 (~$265K)
- · Director Holstein Jens sold 7,500 Common Stock at $47.00 (~$353K)
- · Director Holstein Jens exercised/converted 7,500 Common Stock at $35.30 (~$265K)
- · Director Holstein Jens sold 7,500 Common Stock at $50.00 (~$375K)
- · Director Holstein Jens exercised/converted 7,500 Stock Option (right to buy)
- · Director Holstein Jens exercised/converted 7,500 Stock Option (right to buy)
28-10-2026
EVP, Chief Legal Officer & Sec Stipancich John K sold 3,500 Common Stock at $449.04 (~$1.57M). 4 transactions reported in total. Stipancich John K holds 35,434 shares after the transaction.
- · EVP, Chief Legal Officer & Sec Stipancich John K gifted 200 Common Stock
- · EVP, Chief Legal Officer & Sec Stipancich John K exercised/converted 3,500 Common Stock at $275.69 (~$965K)
- · EVP, Chief Legal Officer & Sec Stipancich John K sold 3,500 Common Stock at $449.04 (~$1.57M)
- · EVP, Chief Legal Officer & Sec Stipancich John K exercised/converted 3,500 Employee Stock Options (right to buy) at $275.69 (~$965K)
28-10-2026
EVP, Chief Medical Officer Marantz Jing L. was awarded 199,822 Common Stock. Marantz Jing L. holds 199,822 shares after the transaction.
- · EVP, Chief Medical Officer Marantz Jing L. was awarded 199,822 Common Stock
- · EVP, Chief Medical Officer Marantz Jing L. was awarded 275,061 Stock Option (right to buy)
28-10-2026
Chief Commercial Officer Hopman Mark sold 821 Common Stock at $20.00 (~$16.4K). Hopman Mark holds 54,513 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Commercial Officer Hopman Mark sold 821 Common Stock at $20.00 (~$16.4K)
28-10-2026
EVP & Chief Tech & Ops Officer Lefebvre Mojgan M sold 11,000 Common Stock at $393.84 (~$4.33M). Lefebvre Mojgan M holds 11,000 shares after the transaction.
- · EVP & Chief Tech & Ops Officer Lefebvre Mojgan M exercised/converted 11,000 Common Stock at $139.83 (~$1.54M)
- · EVP & Chief Tech & Ops Officer Lefebvre Mojgan M sold 11,000 Common Stock at $393.84 (~$4.33M)
- · EVP & Chief Tech & Ops Officer Lefebvre Mojgan M exercised/converted 11,000 Stock Options (Right to Buy)
28-10-2026
Director EASTHAM KARIN sold 14,850 Common Stock at $50.00 (~$743K). EASTHAM KARIN holds 10,247 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director EASTHAM KARIN exercised/converted 10,000 Common Stock at $27.01 (~$270K)
- · Director EASTHAM KARIN sold 14,850 Common Stock at $50.00 (~$743K)
- · Director EASTHAM KARIN exercised/converted 10,000 Stock Option (right to buy)
28-10-2026
EVP and Chief Risk Officer Hu W. Bradford sold 7,099 Common Stock at $168.63 (~$1.2M). Hu W. Bradford holds 42,695 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · EVP and Chief Risk Officer Hu W. Bradford sold 7,099 Common Stock at $168.63 (~$1.2M)
28-10-2026
Director Sarowitz Steven I sold 4,500 Common Stock, par value $0.001 at $170.44 (~$767K). 5 transactions reported in total. Sarowitz Steven I holds 4,354,869 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Sarowitz Steven I sold 4,500 Common Stock, par value $0.001 at $170.44 (~$767K)
- · Director Sarowitz Steven I sold 2,600 Common Stock, par value $0.001 at $171.69 (~$446K)
- · Director Sarowitz Steven I sold 1,200 Common Stock, par value $0.001 at $172.50 (~$207K)
- · Director Sarowitz Steven I sold 500 Common Stock, par value $0.001 at $173.54 (~$86.8K)
- · Director Sarowitz Steven I sold 100 Common Stock, par value $0.001 at $175.22 (~$17.5K)
28-10-2026
Chief Medical Officer Gheuens Sarah sold 7,866 Common stock at $37.69 (~$296K). Gheuens Sarah holds 54,645 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Medical Officer Gheuens Sarah exercised/converted 7,866 Common stock at $25.01 (~$197K)
- · Chief Medical Officer Gheuens Sarah sold 7,866 Common stock at $37.69 (~$296K)
- · Chief Medical Officer Gheuens Sarah exercised/converted 7,866 Stock options (right to buy)
28-10-2026
Director Shea Teresa H was awarded 949.523 Common Stock. Shea Teresa H holds 12,885.04 shares after the transaction.
- · Director Shea Teresa H was awarded 949.523 Common Stock
28-10-2026
Director KENNEDY EDWARD H was awarded 64,724 Common Stock. KENNEDY EDWARD H holds 74,724 shares after the transaction.
- · Director KENNEDY EDWARD H was awarded 64,724 Common Stock
28-10-2026
Director NEU RICHARD W was awarded 3,252.117 Common Stock. NEU RICHARD W holds 123,673.235 shares after the transaction.
- · Director NEU RICHARD W was awarded 3,252.117 Common Stock
28-10-2026
Director Sit Roger J was awarded 1,978.174 Common Stock. Sit Roger J holds 52,885.888 shares after the transaction.
- · Director Sit Roger J was awarded 1,978.174 Common Stock
28-10-2026
Director CRANE ANN B was awarded 1,978.174 Common Stock. CRANE ANN B holds 109,356.902 shares after the transaction.
- · Director CRANE ANN B was awarded 1,978.174 Common Stock
28-10-2026
Director Hardy David L. was awarded 96 Common Stock at $79.19 (~$7.6K). Hardy David L. holds 1,122 shares after the transaction.
- · Director Hardy David L. was awarded 96 Common Stock at $79.19 (~$7.6K)
28-10-2026
Director Garten Yael sold 1,138 Ordinary Shares at $8.30 (~$9.45K). Garten Yael holds 42,352 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Garten Yael sold 1,138 Ordinary Shares at $8.30 (~$9.45K)
28-10-2026
Director ROLLINS JAMES D III bought 10,000 Dep Shares-int in 5.70% Ser I Non-Cum Perp Pref Stk at $19.43 (~$194K). ROLLINS JAMES D III holds 10,000 shares after the transaction.
- · Director ROLLINS JAMES D III bought 4,000 Dep Shares-int in 4.50% Ser H Non-Cum Perp Pref Stk at $14.86 (~$59.4K)
- · Director ROLLINS JAMES D III bought 10,000 Dep Shares-int in 5.70% Ser I Non-Cum Perp Pref Stk at $19.43 (~$194K)
28-10-2026
Group President - SAO Jennings Steven Joseph gifted 470 Common Stock. Jennings Steven Joseph holds 3,020.9137 shares after the transaction.
- · Group President - SAO Jennings Steven Joseph gifted 470 Common Stock
28-10-2026
Chief Scientific Officer Gao Hanlin had withheld for taxes 1,645 Common Stock at $20.22 (~$33.3K). Gao Hanlin holds 984,472 shares after the transaction.
- · Chief Scientific Officer Gao Hanlin had withheld for taxes 1,645 Common Stock at $20.22 (~$33.3K)
Get daily alerts with 10 investment signals, 8 risk alerts, 6 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Insider Trading Pulse
🇺🇸 More from United States
View all →October 21, 2026
US Pre-Market SEC Filings Roundup — October 21, 2026
US Pre-Market SEC Filings Roundup
October 21, 2026
US Corporate Board Director Changes SEC Filings — October 21, 2026
US Corporate Board Director Changes SEC Filings
October 21, 2026
S&P 500 Consumer Discretionary Sector SEC Filings — October 21, 2026
S&P 500 Consumer Discretionary Sector SEC Filings
October 21, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings — October 21, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings